Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma

Oral Oncology

Volumn 40, Issue 3, 2004, Pages 321-325

  Uehara, Masataka ^a   Sano, Kazuo ^b   Ikeda, Hisazumi ^a   Sekine, Joji ^a   Irie, Akihiko ^a   Yokota, Tomohisa ^a   Tobita, Takayoshi ^a   Ohba, Seigo ^a   Inokuchi, Tsugio ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Oral squamous cell carcinoma; Prognosis; Vascular endothelial growth factor

Indexed keywords

TUMOR MARKER; VASCULOTROPIN;

ARTICLE; CANCER STAGING; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 1642431584     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.08.020     Document Type: Article

References (26)

1. Folkman J. Tumor angiogenesis. therapeutic implications N Engl J Med. 285:1971;1182-1186.
2. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851-858.
3. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246(4935):1989;1306-1309.
4. Gospodarowicz D., Abraham J.A., Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA. 86(19):1989;7311-7315.
5. Keck P.J., Hauser S.D., Krivi G.et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246(4935):1989;1309-1312.
6. Toi M., Hoshina S., Takayanagi T.et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res. 85:1994;1045-1049.
7. Relf M., LeJeune S., Scott P.A.et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57:1997;963-969.
8. Takahashi Y., Kitadai Y., Corazon D.B.et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55:1995;3964-3968.
9. Uchida S., Shimada Y., Watanabe G.et al. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br. J. Cancer. 77(10):1998;1704-1709.
10. Maeda T., Matsumura S., Hiranuma H.et al. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma. its association with tumour progression and p53 gene status J Clin Pathol. 51:1998;771-775.
11. Wu L.C., D'Amelio F., Fox R.A., Polyakov I., Daunton N.G. Light microscopic image analysis system to quantify immunoreactive terminal area apposed to nerve cells. J Neurosci Methods. 74(1):1997;89-96.
12. Yue L., Iwai M., Furuta I. Evaluation of argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas. Oral Oncol. 35(1):1999;70-76.
13. Schildt E.B., Nylander K., Eriksson M., Hardell L., Magnusson A., Roos G. Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. Int J Oncol. 22(4):2003;861-868.
14. Storkel S., Reichert T., Reiffen K.A., Wagner W. EGFR and PCNA expression in oral squamous cell carcinomas - a valuable tool in estimating the patient's prognosis. Eur J Cancer B Oral Oncol. 29B(4):1993;273-277.
15. Sittel C., Ruiz S., Volling P., Kvasnicka H.M., Jungehulsing M., Eckel H.E. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol. 35(6):1999;583-589.
16. Yoshida K., Yanai T., Iwasaki T.et al. Proliferative potential of canine oral epulides and malignant neoplasms assessed by bromodeoxyuridine labeling. Vet Pathol. 36(1):1999;35-41.
17. Mukhopadhyay D., Chatterjee R., Chakraborty R.N. Cytokinetic studies of oral cancer cells using bromodeoxyuridine labelling in relation to factors influencing prognosis. Eur J Cancer B Oral Oncol. 31B(1):1995;32-36.
18. Sano K., Takahashi H., Fujita S.et al. Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma. J. Oral Pathol. Med. 20(2):1991;53-56.
19. Yamazaki Y., Chiba I., Hirai A.et al. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol. 39(2):2003;163-169.
20. Yao L., Iwai M., Furuta I. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol. 35(1):1999;56-62.
21. Sakai H., Kawano K., Okamura K., Hashimoto N. Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. J. Oral Pathol. Med. 19(1):1990;1-4.
22. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359(6398):1992;843-845.
23. Ferrara N., Winer J., Burton T.et al. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster cells. J. Clin. Invest. 91:1993;160-170.
24. Volm M., Koomagi R., Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer. 74:1997;64-68.
25. Tanigawa N., Matsumura M., Amaya H.et al. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 79(2):1997;220-225.
26. Moriyama M., Kumagai S., Kawashiri S., Kojima K., Kakihara K., Yamamoto E. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncology. 33(5):1997;369-374.